{"id":210110,"name":"PHRMA (PHARMACEUTICAL RESEARCH & MANUFACTURERS OF AMERICA)","slug":"phrma-pharmaceutical-research-manufacturers-of-america","state":"DC","country":"United States of America","description":"Representatives for biopharmaceutical research companies in the U.S.","totalSpending":240000,"filings":20,"yearlySpending":[{"year":2021,"income":240000},{"year":2022,"income":0},{"year":2023,"income":0},{"year":2024,"income":0},{"year":2025,"income":0}],"issues":[{"code":"PHA","display":"Pharmacy"},{"code":"MMM","display":"Medicare/Medicaid"}],"firms":["ROBERTI GLOBAL (F/K/A ROBERTI WHITE, LLC)"],"lobbyists":["STEVEN IRIZARRY","VINCENT ROBERTI, SR.","DREW COLE"],"govEntities":["HOUSE OF REPRESENTATIVES","SENATE"],"sampleDescriptions":["Promoting public policy, medical research and development, ensuring access to medicines.","Issues related to Medicare Parts B and D, including coverage and reimbursement.\n\nIssues related to H.R. 3 (Lower Drug Costs Now Act).","Issues relating to drug pricing, value and transparency, generally.\nIssues relating to medical research and development, as well as access to medicines","Issues relating to drug pricing, value and transparency, generally.\nIssues relating to medical research and development, as well as access to medicines","Issues related to Medicare Parts B and D, including coverage and reimbursement.\n\nIssues related to H.R. 3 (Lower Drug Costs Now Act)."]}